Ecto is a digital biology company developing technology to make protein production more efficient and sustainable
Ecto has raised $560K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2023.
Ecto's investors include National Science Foundation, Seventure Partners, Rabobank, Aqua Spark, The Yield Lab.
Ecto is headquartered in Atlanta, United States.
Ecto is a digital biology company developing technology to make protein production more efficient and sustainable
Ecto is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ecto — Funding & Investors." VCBacked, October 20, 2023, https://www.vcbacked.co/company/ecto. Accessed July 21, 2026.
VCBacked. (2023). Ecto — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/ecto
{{cite web |title=Ecto — Funding & Investors |url=https://www.vcbacked.co/company/ecto |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated